AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

Translating regenerative medicine from lab research to large-scale clinical and commercial production requires robust, scalable, and tightly controlled ...

In-silico modeling aids in early decision-making for poorly soluble drugs, which are prevalent in development pipelines. AI, ML, and statistical algorithms guide ...